Carbylan Therapeutics Lands $5,000,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=763a23e0-6c95-488a-99dd-f4d2e6253e5f - Date
10/14/2014 - Company Name
Carbylan Therapeutics - Mailing Address
3181 Porter Drive Palo Alto, CA 94304 USA - Company Description
Carbylan Therapeutics develops and markets bioresponsive medical products to enhance healing, provide better surgical outcomes and improve patients’ quality of life. Carbylan is committed to quality in all areas of its business by complying with regulatory requirements and improving the effectiveness of its quality system. - Website
http://www.carbylan.com - Transaction Type
Debt - Transaction Amount
$5,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
